Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin

Hoofnagle, 1997, Hepatology, 26, 10.1002/hep.510260543 Alter, 1999, N Engl J Med, 341, 556, 10.1056/NEJM199908193410802 Blatt, 2000, J Viral Hepat, 7, 196, 10.1046/j.1365-2893.2000.00221.x Reddy, 1999, Hepatology, 30, 787, 10.1002/hep.510300319 McHutchison, 2000, Gastroenterology, 119, 1317, 10.1053/gast.2000.19289 Kinzie, 2001, J Viral Hepat, 8, 264, 10.1046/j.1365-2893.2001.00292.x Fleckenstein, 1998, Hepatology, 28, 283a Lawitz, 2001, Hepatology, 34, 1000a, 10.1053/jhep.2001.28458 Siddiqui, 2001, Hepatology, 34, 1637a Zeuzem, 1996, Hepatology, 23, 366 Lam, 1997, Hepatology, 26, 226, 10.1002/hep.510260130 Neumann, 1998, Science, 282, 103, 10.1126/science.282.5386.103 Zeuzem, 2001, Gastroenterology, 120, 1438, 10.1053/gast.2001.24006 Neumann, 2000, J Infect Dis, 182, 28, 10.1086/315661 Layden, 2002, J Viral Hepat, 9, 334, 10.1046/j.1365-2893.2002.00376.x Neumann, 2000, Hepatology, 32, 318a Lam, 1994, Dig Dis Sci, 39, 2660, 10.1007/BF02087706 McHutchison, 2001, Hepatology, 34, 421a Lam, 1997, Dig Dis Sci, 42, 178, 10.1023/A:1018865928308 Layden, 2002, J Viral Hepat, 9, 340, 10.1046/j.1365-2893.2002.00377.x Jessner, 2001, Lancet, 358, 1241, 10.1016/S0140-6736(01)06356-5 Sterling, 2001, Hepatology, 34, 418a Gale, 1997, Virology, 14, 217, 10.1006/viro.1997.8493 Gale, 1998, Mol Cell Biol, 18, 5208, 10.1128/MCB.18.9.5208 Taylor, 1999, Science, 285, 107, 10.1126/science.285.5424.107 Cerny, 1999, Hepatology, 30, 595, 10.1002/hep.510300312